Non-Celiac Wheat Sensitivity: Permanent or Transient Condition?
Launched by UNIVERSITY OF PALERMO · Jun 30, 2016
Trial Information
Current as of August 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called Non-Celiac Wheat Sensitivity (NCWS), which causes symptoms similar to gluten intolerance but is different from celiac disease and wheat allergy. Unlike celiac disease, where people must avoid gluten for life, it’s not clear if people with NCWS need to avoid wheat permanently or if their sensitivity might go away over time. This study aims to find out how many patients still need to avoid wheat and how many continue to have symptoms when wheat is reintroduced into their diet.
People who might be eligible for this study are those who were previously diagnosed with NCWS using a special test called a double-blind placebo-controlled wheat challenge, which helps confirm the sensitivity by carefully reintroducing wheat without the patient knowing when they are getting it. Participants can expect to be monitored to see if they are still avoiding wheat and whether they still experience symptoms related to wheat intake. This study is important because it could help doctors better understand how to manage NCWS and whether a strict wheat-free diet is always necessary.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients previously diagnosed with NCWS by DBPC challenge.
- Exclusion Criteria:
- • The 22 patients, included in the previous study, who tested positives for anti-endomysial antibodies (EmA) in the culture medium of the duodenal biopsies, even if the villi/crypts ratio in the duodenal mucosa was normal, were excluded from the present study.
About University Of Palermo
The University of Palermo, a distinguished institution located in Italy, is dedicated to advancing medical research and education through innovative clinical trials. Renowned for its commitment to scientific excellence, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct research that addresses critical healthcare challenges. By fostering collaborations with leading researchers and healthcare professionals, the University of Palermo aims to translate scientific findings into effective therapies, ultimately contributing to improved patient outcomes and public health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sciacca, Agrigento, Italy
Palermo, , Italy
Patients applied
Trial Officials
Antonio Carroccio, MD
Principal Investigator
Department of Internal Medicine, Giovanni Paolo II Hospital of Sciacca
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials